Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor World Review.
Press releases published on May 14, 2025
DeFi Development Corp. Reports First Quarter 2025 Financial Results and Provides Strategic Update on Solana Treasury Activity
GlobeNewswire
·
May 14, 2025
BOCA RATON, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (“DeFi Dev Corp” or the “Company”), a public-market vehicle focused on long-term Solana (“SOL”) accumulation, today announced financial results for the first quarter …
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
-- Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data anticipated in 3Q 2025 -- -- Cash resources of $42.2 million as of March 31, 2025, expected to fund operations into 1Q 2026 -- …
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
GlobeNewswire
·
May 14, 2025
BRISBANE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate …
Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update
GlobeNewswire
·
May 14, 2025
ATRN-119, our ATR inhibitor, exhibits early evidence of single agent, anti-tumor activity and is progressing toward the recommended Phase 2 dose (RP2D) in the ongoing ABOYA-119 clinical trial Three patients in the 550 mg twice daily cohort in the ongoing …
Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 14, 2025
Actively enrolling nAMD patients in a Phase 1 trial of TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat neovascular and exudative diseases of the retina; initial …
Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced financial …
Redfin and Magnite Join Forces to Give Advertisers Priority Access to Audience Targeting Across the Homebuying Journey
GlobeNewswire
·
May 14, 2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Redfin (NASDAQ: RDFN), the technology-powered real estate brokerage, has selected Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, as its preferred SSP to power data-driven deals. …
SailPoint to Announce Fiscal First Quarter 2026 Results on June 11, 2025
GlobeNewswire
·
May 14, 2025
AUSTIN, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise identity security, will report its fiscal first quarter 2026 financial results before the US markets open on Wednesday, June 11, 2025. SailPoint will …
LGI Homes is Now Selling New Homes at Henson Creek Farms near Spartanburg, SC
GlobeNewswire
·
May 14, 2025
SPARTANBURG, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce that new homes are now for sale at Henson Creek Farms, a brand-new community located in Moore, South Carolina, just southwest of Spartanburg. “With …
Sow Good Reports First Quarter 2025 Results
GlobeNewswire
·
May 14, 2025
IRVING, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- Sow Good Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, is reporting financial and operating results for first quarter ended March 31, 2025. “We …
aTyr Pharma Advances ATYR0101 to IND Candidate Stage for Pulmonary Fibrosis
GlobeNewswire
·
May 14, 2025
Preclinical data demonstrate ATYR0101’s unique anti-fibrotic mechanism through interaction with LTBP-1. ATYR0101 to be showcased in oral presentation at the American Thoracic Society (ATS) 2025 Respiratory Innovation Summit. SAN DIEGO, May 14, 2025 (GLOBE …
Viasat and Blue Origin to Partner on Launch Telemetry Demonstration for NASA Communications Services Project
GlobeNewswire
·
May 14, 2025
CARLSBAD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Viasat Inc. (NASDAQ: VSAT), a global leader in satellite communications (SATCOM), today announced it has selected Blue Origin as its launch mission partner to support Viasat’s demonstration of its InRange …
Project EverGreen and ScottsMiracle-Gro Expand Green Spaces at Heat-stressed Phoenix Park
GlobeNewswire
·
May 14, 2025
PHOENIX, May 14, 2025 (GLOBE NEWSWIRE) -- Project EverGreen and ScottsMiracle-Gro have launched the second phase of a major renovation at Barrios Unidos Park that includes planting of trees, grass and native plants. This transformative effort, part of …
Chapman University Releases International Housing Affordability Report Revealing None of the 95 Major Markets Affordable
GlobeNewswire
·
May 14, 2025
ORANGE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- For the first time in the report’s 21-year history, none of the 95 major housing markets analyzed across eight nations qualifies as “affordable.” This alarming statistic headlines the newly released 2025 …
Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
GlobeNewswire
·
May 14, 2025
Published Research Demonstrates the Value of BVA in Meeting Key Goal of Identifying Anemia in Heart Failure Patients Oak Ridge, TN, May 14, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), Daxor Corporation, the global leader in blood volume …
FDA and Cingulate Aligned with Filing Requirements for New Drug Application for Lead ADHD Asset CTx-1301
GlobeNewswire
·
May 14, 2025
Pre-NDA Minutes from April 2, 2025, Meeting Received NDA Submission Planned this Summer KANSAS CITY, Kan., May 14, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) …
Algorhythm Holdings to Announce its Financial Results for the First Quarter 2025
GlobeNewswire
·
May 14, 2025
Fort Lauderdale, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm Holdings” or the “Company”) (NASDAQ: RIME) -- AI technology and consumer electronics holding company -- today announced that its earnings for its first quarter …
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)
GlobeNewswire
·
May 14, 2025
NEWPORT BEACH, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital,” “we,” “our,” or “us”), a wholly owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), today announced its planned filing of a Schedule 13D with the U.S. Securities …
IN8bio Presents Preclinical Data Highlighting Potential of INB-619 T Cell Engager (TCE) for Autoimmune Disease at ASGCT 2025
GlobeNewswire
·
May 14, 2025
Powerful B cell Targeting: INB-619 precisely targets and eliminates B cells from lupus patient samples, including harmful IgG1 and IgM antibodies, demonstrating potential as a treatment for autoimmune diseases Innovative Next Generation TCE Platform: INB- …
Domestic Metals Announces Appointment of Gordon Neal as President
GlobeNewswire
·
May 14, 2025
VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (“Domestic” or the “Company”) (TSXV:DMCU; OTC:DMCUF; Frankfurt: 03E) announces the appointment of Gordon Neal as President of the Company. Mr. Neal has had a notable and …